Key result
Symptomatic presentation of cancer-associated thrombosis was associated with a tangible illness identity, whereas asymptomatic patients did not perceive recurrent thrombosis as a health threat.
Why the study?
Whether the clinical presentation of cancer-associated thrombosis (symptomatic versus asymptomatic) impacts illness perception was poorly elucidated.
Does the clinical presentation of cancer-associated thrombosis (symptomatic vs. asymptomatic) impact illness perception?
Does the clinical presentation of cancer-associated thrombosis (symptomatic vs. asymptomatic) impact illness perception?
The clinical presentation of cancer-associated thrombosis significantly impacts illness perception, suggesting that communication should be tailored to whether the patient is symptomatic or asymptomatic.
Explores illness perception in CAT by presentation; leaves open effects on outcomes and needs prospective validation.
INTRODUCTION: Patients with cancer, have reported cancer-associated thrombosis (CAT), a distressing event in their overall illness. However, whether the clinical presentation of CAT; symptomatic versus asymptomatic, impacts illness perception is poorly elucidated. The aim of this study was to explore illness perception in patients with CAT, stratified by the clinical presentation. MATERIALS AND METHODS: In a qualitative design, we conducted a three-step workshop. Patients were included from a specialised cardiology care unit for oncology patients. Data analysis was performed using framework analysis. The analytic framework was based on the five components of illness perception: (1) identity of illness, (2) causal beliefs, (3) timeline beliefs, (4) beliefs about control/cure and (5) consequences. RESULTS: Elleven patients with CAT participated in the workshop; five symptomatic and six asymptomatic. Whitin each category of illness perception following notions emerged (1) the identity of CAT was only tangible for symptomatic participants, (2) the aetiology was considered important information for symptomatic participants, which was in contrast to asymptomatic participants, (3) asymptomatic participant did not consider recurrent CAT a threat towards their health, (4) asymptomatic participants were prone to information overload, whilst information was imperative to the sense of control in symptomatic participants, (5) low molecular weight heparin treatment was accepted in symptomatic participants due to remission of symptoms. CONCLUSIONS: The clinical presentation of CAT (asymptomatic/symptomatic) proved essential to illness perception. These findings indicate that information level and communication within the medical consultation, should actively consider the clinical presentation of CAT in order to optimize management and compliance.
No takes yet. Share an insight, caveat, or question.
Nouhravesh et al. (2022) studied Cancer-associated thrombosis (n=11). Symptomatic clinical presentation vs. Asymptomatic clinical presentation was evaluated on Illness perception (identity, causal beliefs, timeline, control/cure, and consequences). Symptomatic presentation of cancer-associated thrombosis was associated with a tangible illness identity, whereas asymptomatic patients did not perceive recurrent thrombosis as a health threat.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: